Learn More
Medchemexpress LLC PROTAC EZH2 Degrader-1 | 2641601-67-2 | 99.4% | 942.15 | 25 MG

Supplier: Medchemexpress LLC 25MGHY147525
PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC EZH2 Degrader that inhibits EZH2 methyltransferase activity with an IC50 of 2.7 nM. EZH2 is critical in many tumorigenesis and development processes.
- Potently inhibits EZH2 methyltransferase activity (IC50: 2.7 nM).
- Demonstrates anti-proliferative activity against human EOL1, MV4-11, Pfeiffer, RS4-11, and WSUDLCL2 cells.
- Inhibits cell viability in H128-LM, H128-BPM, H128 wildtype, and H128-Mut cells.
- Enhances sensitivity of H128-LM cells to Carboplatin, VP16, and VM26.
- Exhibits antitumor activity in H128-LM xenograft mouse models, prolonging survival when combined with Carboplatin, VP16, or VM26.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.